Evolus, Inc. (NASDAQ:EOLS) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET

Company Participants

David Erickson - VP, IR

David Moatazedi - President and CEO

Rui Avelar - CMO and Head, Research & Development

Sandra Beaver - CFO

Conference Call Participants

Annabel Samimy - Stifel

Navann Ty - BNP

Louise Chen - Cantor Fitzgerald

Doug Tsao - H.C. Wainwright

Serge Belanger - Needham & Company

Operator

Greetings and welcome to the Evolus Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

I would now turn the conference over to your host, Mr. David Erickson, Vice President of Investor Relations.

David Erickson

Thank you, operator and welcome to everyone joining us on today's call. With me today are David Moatazedi, President and Chief Executive Officer; Rui Avelar, Chief Medical Officer, Head of R&D; and Sandra Beaver, Chief Financial Officer.

Our prepared remarks today will include forward-looking statements within the meaning of United States Securities Laws and management may make additional forward-looking statements in response to your questions.

Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the company's business, strategy, operations, or financial performance.

A detailed discussion of the risks and uncertainties that the company faces is contained in its annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K.

Actual results may differ materially from those expressed in or implied by the forward-looking statements. The company undertakes no obligation to update or review any estimate, projection, or forward-looking statements.

Additionally, today's discussion will include non-GAAP financial measures, which should be considered in addition to and not as a substitute for or in isolation from our GAAP results.

A reconciliation of GAAP to non-GAAP results may be found in our earnings release, which was furnished with our Form 8-K filed today with the SEC and on our Investor Relations website at evolus.com.

Following the conclusion of today's call, a replay will be available on our website at evolus.com.

And with that, I'll turn the call over to David.

David Moatazedi

Thank you, David. We're pleased to report another quarter of continued above-market sales growth that reflected record sales and accelerating growth over the first quarter. In the second quarter, we achieved all-time highs across several leading indicators, including expansion of new accounts and increased consumer usage of Jeuveau through our Evolus Rewards consumer loyalty program.